Investors
Ally Bridge Group is a global healthcare investment management firm focused on high-impact life science innovation. The firm was founded in 2013 by Frank Yu, Chief Executive Officer and Chief Investment Officer, and manages assets from offices in New York and Hong Kong.
Since their establishment, Ally Bridge Group has been the lead or co-lead on over $6 billion of transactions across healthcare subsectors, with a mission to generate superior risk-adjusted returns for investors while seeking to address unmet medical needs. Ally Bridge Group aims to achieve this by blending deep scientific and clinical research with proven M&A and capital markets expertise.
The principals of Claret Capital Partners have been providing growth financing to innovative businesses for more than 20 years, during which time they have backed more than 200 companies. Claret’s mission is to provide Technology and Life Science businesses with the Growth Capital that they need to succeed, while providing a less dilutive alternative to traditional equity fundraising.
The Claret team have a significant track record of partnering with a large number of growth businesses and are committed to continuing to be a trusted, market leader in the European eco-system.
EQT is one of Europe’s largest and most experienced healthcare investment firms. With a track record going back more than 25 years, it has built up an investment house that is dedicated to only one task: seeking, nurturing and growing healthcare investment opportunities with the potential to have a positive impact on society. EQT believes such opportunities create the most value for all parties.
From its offices in Amsterdam, Munich and Boston, its team aims to back the smartest inventors with the best ideas. While their goal is to develop products and technologies that have a positive impact on society, their objective is to help inventors achieve their goals. By definition, success is often accompanied by financial returns. The combination of contributing to society and the prospect of associated financial returns is why investors entrust EQT to invest their capital.
Since its inception, the Fortress Credit business has been active across both direct lending and public credit markets with the flexibility to invest throughout the capital structure and experience deploying capital through varied economic and credit cycles.
Operating as one team across liquid and private credit with 200+ investment professionals, Fortress has efficiently provide a wide variety of debt and capital solutions for borrowers and sponsors.
H. Carnegie & Co. is one of Australia’s premier alternative asset managers based in Sydney, Australia. The fund was launched in 2011 by Mark Carnegie who has a long and successful track record in principal investing in the Australian, Asian and North American markets.
Carnegie, with over $320mn of funds under management, targets investments across venture and expansion capital, stressed/complex transactions, operating real estate and shareholder activism. The fund includes two innovation investment fund (“IIF”) allocations from the Australian Government totaling $60mn for venture related investments. In March 2013, Carnegie was awarded an IIF allocation of $40mn, the biggest ever made under this program.
Mark Carnegie, his team and the Carnegie investment committees have a significant and extensive profile and network within the Australian private investment markets resulting in an unparalleled flow of proprietary Australian-based investment opportunities and the support of a strong network of co-investors.
Horizon 3 Healthcare is a healthcare-focused firm focused on build innovative companies in the medical device and biopharma space. With a powerful team made up of seasoned entrepreneurs, life science specialists and experienced investors who are experts in their respective areas, Horizon 3 Healthcare has been extremely successful in identifying talented life sciences teams and companies with huge potential.
With a wide range of public and private companies around the world, Horizon 3 Healthcare has achieved excellent returns for their investors all while driving forward best in class technologies to help patients in need.
Hostplus is a national superannuation fund for those that live and love Australian hospitality, tourism, recreation and sport. The Australian Hotels Association and United Voice jointly established the fund in 1987. Hostplus is one of the largest in the country with over one million members, 170,000 employers and $30 billion in funds under management.
Built on a foundation that leverages 30 years of North American venture capital experience, the Lumira Ventures team has substantial experience helping to build transformational health and life science companies.
Their goal is to make investments in market leading companies and work in partnership with those companies to develop and implement strategies to build significant businesses that in turn allow us to generate profitable exits that maximize returns within a reasonable time frame.
As partners in our businesses they are committed to the success of our portfolio companies. We roll up our sleeves and work side by side with our entrepreneurs, their management teams and our syndication partners – leveraging our internal resources, knowledge networks, deep industry expertise and relationships, as well as our operational and leadership experience to help the businesses achieve their full potential.
Cardiac Dimensions has had a multi-national, multi-billion dollar market capitalization strategic partner since 2022. This partner has provided substantial capital to the company as well as market guidance and product validation.
